FR940524-2-00045 FR940524-2-00027 (1) Assure complete reporting by hospitals and other facilities. (2) Assure complete reporting by physicians, surgeons, and all other health care practitioners diagnosing or providing treatment for cancer patients. (3) Permit the statewide cancer registry to access all records that would identify cases of cancer or would establish characteristics of the cancer, treatment of the cancer, or medical status of any individual patient. (4) Report cancer case data to the statewide cancer registry in such a format, with such data elements, and in accordance with such standards of quality, timeliness, and completeness, as may be established by CDC. (5) Protect the confidentiality of all cancer data reported to the statewide registry, including a prohibition on disclosure to any person of information reported to the statewide registry that identifies or could lead to the identification of an individual cancer patient, except for disclosure to other State cancer registries and local and State health officials. (6) Disclose confidential case data, in accordance with State law, to cancer researchers. (7) Authorize the conduct, by the statewide cancer registry or other persons and organizations, of studies utilizing statewide cancer registry data. (8) Protect individuals complying with the law, including provisions specifying that no person shall be held liable in any civil action with respect to a cancer case report provided to the statewide cancer registry, or with respect to access to cancer case information provided to the statewide cancer registry. [Sec. 399H(c)(2)(D)]. Recipients of funds under Part I or Part II must provide, as part of their application, assurances that they will provide for the authorization under State law of the statewide cancer registry, including the promulgation of regulations within one year and within two years, respectively. Continued funding will be contingent on the enactment of authorizing State legislation and promulgation of all required State regulations. Human Subjects If the proposed project involves research on human subjects, the applicant must comply with the Department of Health and Human Services Regulations, 45 CFR part 46, regarding the protection of human subjects. Assurance must be provided to demonstrate that the project will be subject to initial and continuing review by an appropriate institutional review committee. The applicant will be responsible for providing assurance in accordance with the appropriate guidelines and form provided in the application kit. Application Submission and Deadline The Program Announcement and application kit were sent to all eligible applicants in March 1994. Where To Obtain Additional Information A complete program description, information on application procedures, an application package and business management technical assistance may be obtained from Leah D. Simpson, Grants Management Specialist, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., room 314, Mailstop E&hyph;18, Atlanta, GA 30305, telephone (404) 842&hyph;6803. Programmatic technical assistance may be obtained from Rosemarie McIntyre, M.S., Epidemiology and Statistics Branch, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway, NE., Mailstop K&hyph;55, Atlanta, GA 30341&hyph;3724, telephone (404) 488&hyph;4682. Please refer to Announcement 426 when requesting information and submitting an application. Potential applicants may obtain a copy of ``Healthy People 2000'' (Full Report, Stock No. 017&hyph;001&hyph;00474&hyph;0) or ``Healthy People 2000'' (Summary Report, Stock No. 017&hyph;001&hyph;00473&hyph;1) referenced in the ``Introduction'' through the Superintendent of Documents, Government Printing Office, Washington, DC 20402&hyph;9325, telephone (202) 783&hyph;3238. Copies of the following may be obtained by calling DeVicki Willis, Centers for Disease Control and Prevention (CDC) at (404) 488&hyph;4682: (1) American Association of Central Cancer Registries, ``Working Group on Pre-Invasive Cervical Neoplasia and Population-Based Cancer Registries, Final Subcommittee Report,'' (April 1993); (2) American Association of Central Cancer Registries, ``Data Standards, Standards for Cancer Registries,'' Volume II, (September 1993); (3) American Association of Central Cancer Registries, ``Standards for Completeness, Quality, Management, and Analysis of Data, Standards for Cancer Registries,'' Volume III, (December 1993). Dated: May 18, 1994. Ladene H. Newton, Acting Associate Director for Management and Operations, Centers for Disease Control and Prevention (CDC). [FR Doc. 94&hyph;12596 Filed 5&hyph;23&hyph;94; 8:45 am] BILLING CODE 4163&hyph;18&hyph;P
